Report cover image

Rigel Pharmaceuticals, Inc. - Company Profile and SWOT Analysis

Publisher MarketLine
Published Aug 21, 2025
Length 40 Pages
SKU # MTLN20412600

Description

Rigel Pharmaceuticals, Inc. - Company Profile and SWOT Analysis

Summary

Rigel Pharmaceuticals, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Rigel Pharmaceuticals, Inc. (Rigel or 'the company') is a biotechnology company that discovers, develops and provides novel small-molecule drugs. Its products are used in immunology, inflammatory, autoimmune, oncology, hematology and immuno-oncology related therapeutic areas. Its products include autoimmune hemolytic anemia, and immune thrombocytopenic. Rigel collaborates with various pharmaceutical companies to develop therapeutic drugs. The company markets its products through partnerships in various geographical regions including North America, Europe, and Asia-Pacific. The company is headquartered in South San Francisco, California, the US.

Scope
  • Detailed information on Rigel Pharmaceuticals, Inc. required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Rigel Pharmaceuticals, Inc. in the form of a SWOT analysis
  • An in-depth view of the business model of Rigel Pharmaceuticals, Inc. including a breakdown and examination of key business segments
  • Intelligence on Rigel Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Rigel Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
  • Gain understanding of Rigel Pharmaceuticals, Inc. and the factors that influence its strategies.
  • Track strategic initiatives of the company and latest corporate news and actions.
  • Assess Rigel Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
  • Support sales activities by understanding your customers' businesses better.
  • Stay up to date on Rigel Pharmaceuticals, Inc.'s business structure, strategy and prospects.

Table of Contents

40 Pages
Company Snapshot
Rigel Pharmaceuticals, Inc.: Company Overview
Rigel Pharmaceuticals, Inc.: Overview and Key Facts
Rigel Pharmaceuticals, Inc.: Overview
Rigel Pharmaceuticals, Inc.: Key Facts
Rigel Pharmaceuticals, Inc.: Key Employees
Rigel Pharmaceuticals, Inc.: Key Employee Biographies
Rigel Pharmaceuticals, Inc.: Major Products and Services
Rigel Pharmaceuticals, Inc.: Management Statement
Rigel Pharmaceuticals, Inc.: Key Competitors
Rigel Pharmaceuticals, Inc.: Company Analysis
Rigel Pharmaceuticals, Inc.: Business Description
Rigel Pharmaceuticals, Inc.: SWOT Analysis
Rigel Pharmaceuticals, Inc.: SWOT Overview
Rigel Pharmaceuticals, Inc.: Strengths
Rigel Pharmaceuticals, Inc.: Weaknesses
Rigel Pharmaceuticals, Inc.: Opportunities
Rigel Pharmaceuticals, Inc.: Threats
Rigel Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Rigel Pharmaceuticals, Inc.: Financial Deals Overview
Rigel Pharmaceuticals, Inc.: Targets and Partners
Rigel Pharmaceuticals, Inc.: Top Deals 2021 - 2025YTD*
Rigel Pharmaceuticals, Inc.: Mergers and Acquisitions
Rigel Pharmaceuticals, Inc.: Partnership
Rigel Pharmaceuticals, Inc.: Recent Developments
Rigel Pharmaceuticals, Inc.: News and Events Summary
Rigel Pharmaceuticals, Inc.: Corporate Governance
Rigel Pharmaceuticals, Inc.: Financial Performance
Rigel Pharmaceuticals, Inc.: Research & Development
Rigel Pharmaceuticals, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: Rigel Pharmaceuticals, Inc.: Key Facts
Table 2: Rigel Pharmaceuticals, Inc.: Key Employees
Table 3: Rigel Pharmaceuticals, Inc.: Key Competitors
Table 4: Rigel Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 5: Rigel Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
Table 6: Rigel Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
Table 7: Rigel Pharmaceuticals, Inc.: Targets and Partners
Table 8: Rigel Pharmaceuticals, Inc.: Top Deals 2021 - 2025YTD*
Table 9: Rigel Pharmaceuticals, Inc.: M&A Volume and Value Trend (2021 - YTD*2025)
Table 10: Rigel Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2021 - YTD*2025)
Table 11: Rigel Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2021 - YTD*2025)
Table 12: Rigel Pharmaceuticals, Inc.: News and Events Summary
Table 13: Rigel Pharmaceuticals, Inc.: Corporate Governance
Table 14: Rigel Pharmaceuticals, Inc.: Financial Performance
Table 15: Rigel Pharmaceuticals, Inc.: Research & Development
Table 16: Rigel Pharmaceuticals, Inc.: Strategy and Operations
List of Figures
Figure 1: Rigel Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Rigel Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2021 - YTD*2025)
Figure 3: Rigel Pharmaceuticals, Inc.: M&A Average Deal Size - Value (US$m)
Figure 4: Rigel Pharmaceuticals, Inc.: M&A Volume and Value Trend (2021 - YTD*2025)
Figure 5: Rigel Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2021 - YTD*2025)
Figure 6: Rigel Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2021 - YTD*2025)

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us